Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Connecticut
About this trial
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
LDL-C ≥ 130 mg/dL
Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
Aged 18 to 70 years
Disqualifiers
Renal disease
Liver disease
Diabetes
Heart disease
Trial design
Design model
Parallel
Treatments tested in this trial
Milk Polar Lipid-Rich Dairy Powder
DrugEffects of the addition of 6.5 g of milk polar lipids to dairy powder.
Dairy Powder
Dietary supplementEffects of dairy control powder
Treatment groups
130 Participants
are divided into 2 treatment groupsGroup A: MPL-rich dairy powderExperimental treatment 1 intervention
Group B: Control dairy powderPlacebo comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change from Baseline Serum LDL Cholesterol at 8 weeks
Measurement of serum LDL cholesterol (mg/dL) at the beginning and end of 8-week intervention arm.
Time frame
8 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Connecticut
Lead sponsor
Dairy Management Inc.
Collaborator
Source ClinicalTrials.gov